Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Fox Communications

- PMLiVE

Eisai doubles Belviq’s US sales force

Will take on more than 200 new contact sales reps to promote obesity drug

- PMLiVE

US obesity campaign launches

The OAC’s ‘Your Weight Matters’ campaign aims to encourage Americans to discuss weight issues with their healthcare providers

- PMLiVE

Orexigen files obesity drug in EU

Company expects Contrave to show positive cardiovascular safety 

- PMLiVE

Novo backs Victoza’s prospects in Alzheimer’s

Chief science officer says phase III trial could begin in three years

- PMLiVE

How Russian lifestyles are affecting the nation’s healthcare

Russian lifestyles present a significant challenge to the country’s health services

- PMLiVE

Eisai launches online obesity awareness drive

Wants US employers to realise the cost of obesity

- PMLiVE

Malaria vaccine gives “unprecedented” results

Able to protect 12 out of 15 people in phase I trial

- PMLiVE

Boehringer eyes obesity market

Aims to widen metabolism portfolio beyond diabetes

- PMLiVE

Mobile campaign aims to tackle childhood obesity

OpenMarket to run programme for Blue Cross of Idaho Foundation

- PMLiVE

Pfizer wins new European approval for Prevenar 13

Expands use of pneumococcal disease vaccine to cover people aged 18 to 49

- PMLiVE

Novartis enters developing nations vaccines partnership

Will work with Biological E to deliver vaccines for typhoid and paratyphoid A fevers

- PMLiVE

AstraZeneca and NGM form diabetes/ obesity partnership

Will use MedImmune arm to develop treatments that target gastrointestinal hormones

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links